LB Pharmaceuticals Inc Common Stock(LBRX)

Biotechnology · New York, NY

$34.17-0.45 (-1.29%)

Delayed quote: Oct 6, 2026, 12:55 PM EDT

Compare

Interest Coverage Ratio: N/A

Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.

The interest coverage ratio is N/A as of Tuesday, October 6, 2026.

Interest Expense|Total Debt|Debt/Equity|Operating Margin|All Metrics

LBRX Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

N/A

LBRX Competitors' Interest Coverage Ratio

LBRX

LB Pharmaceuticals Inc Common Stock

Current

Market Cap

$979.98M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MGTX

MeiraGTx Holdings plc

vs LBRX

Market Cap

$980.52M

Interest Coverage Ratio

-8.69x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PCRX

Pacira BioSciences, Inc.

vs LBRX

Market Cap

$982.98M

Interest Coverage Ratio

2.28x

TTM Avg

2.28x

3Y Avg

3.01x

5Y Avg

2.79x

AKTS

Aktis Oncology, Inc.

vs LBRX

Market Cap

$976.32M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRCT

PROCEPT BioRobotics Corporation

vs LBRX

Market Cap

$991.81M

Interest Coverage Ratio

-28.96x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LTGO

Latigo Biotherapeutics Inc.

vs LBRX

Market Cap

$1.00B

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SVRA

Savara Inc.

vs LBRX

Market Cap

$952.91M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KURA

Kura Oncology, Inc.

vs LBRX

Market Cap

$949.00M

Interest Coverage Ratio

-200.81x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SPTX

Seaport Therapeutics, Inc. Common Stock

vs LBRX

Market Cap

$950.17M

Interest Coverage Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MLTX

MoonLake Immunotherapeutics

vs LBRX

Market Cap

$938.92M

Interest Coverage Ratio

-33.78x

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
LB Pharmaceuticals Inc Common Stock (LBRX)	$979.98M	N/A	N/A	N/A	N/A
MeiraGTx Holdings plc (MGTX)vs ›	$980.52M	-8.69x	N/A	N/A	N/A
Pacira BioSciences, Inc. (PCRX)vs ›	$982.98M	2.28x	2.28x	3.01x	2.79x
Aktis Oncology, Inc. (AKTS)vs ›	$976.32M	N/A	N/A	N/A	N/A
PROCEPT BioRobotics Corporation (PRCT)vs ›	$991.81M	-28.96x	N/A	N/A	N/A
Latigo Biotherapeutics Inc. (LTGO)vs ›	$1.00B	N/A	N/A	N/A	N/A
Savara Inc. (SVRA)vs ›	$952.91M	N/A	N/A	N/A	N/A
Kura Oncology, Inc. (KURA)vs ›	$949.00M	-200.81x	N/A	N/A	N/A
Seaport Therapeutics, Inc. Common Stock (SPTX)vs ›	$950.17M	N/A	N/A	N/A	N/A
MoonLake Immunotherapeutics (MLTX)vs ›	$938.92M	-33.78x	N/A	N/A	N/A

Financial Health Indicators

Interest Coverage

N/A

Debt/Equity

0.02

Current Ratio

15.08

Formula: Interest Coverage = EBIT / Interest Expense

Reference ranges:

< 1.5x: EBIT is less than 1.5 times interest expense
1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
3x - 5x: EBIT is between 3 and 5 times interest expense
> 5x: EBIT is more than 5 times interest expense

Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.

Interest Coverage Ratio Formula & Definition

Interest Coverage = EBIT / Interest Expense

The interest coverage ratio measures operating earnings relative to interest expense.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Interest Coverage Ratio: N/A

LBRX Interest Coverage Ratio Metrics

LBRX Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Related Metrics